TB

Tehila Ben-Moshe

Chief Executive Officer

Biond Biologics Ltd

Tel Aviv-Yafo, Tel Aviv District


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Biond Biologics Ltd
Industry
pharmaceuticals
Employees
40.0
Seniority
C suite
Annual Revenue
3500000.0
Total Funding
32000000.0
Latest Funding
Series C

Technologies

Cloudflare DNS Outlook Mobile Friendly Google Font API WordPress.org Google Tag Manager AI Circle

Keywords

pharmaceuticals drug development autoimmune immunooncology platform drug delivery intracellular delivery of biologics pharmaceutical manufacturing biotech immunotherapy cancer therapy biological products intracellular delivery immune evasion bnd-22 bnd-35 bnd-67 inspire technology protein-based biologics antibodies nanobodies enzymes clinical trials immune checkpoint inhibitor tumor microenvironment immune-modulatory preclinical development clinical-stage biotech novel therapies translational research biopharmaceuticals drug delivery platform targeted therapy biologic payload pharmacokinetics biodistribution chemical modification cell internalization tumor targeting kras targeting braf targeting hpv-e7 biologic development monoclonal antibodies immune-modulatory pipeline first-in-class products late stage drug development fda approval biotech innovation real-world patient samples scientific research clinical data regulatory affairs collaborations biotech leadership scientific publications biologics development tumor immunology medical health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans